Controlled-release compositions

Details for Australian Patent Application No. 2003275854 (hide)

Owner Labopharm Inc. Labopharm (Barbados) Limited Labopharm Europe Limited

Inventors Ouzerourou, Rachid; Lenaerts, Vincent; Ouadji-Njiki, Patricia Laure; Rahmouni, Miloud; Gervais, Sonia; Bacon, Jonathan; Smith, Damon

Agent Griffith Hack

Pub. Number AU-B-2003275854

PCT Number PCT/CA03/01637

PCT Pub. Number WO2004/038428

Priority 10/281,026 25.10.02 US; 60/510,000 10.10.03 US

Filing date 27 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 11 September 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

19 February 2004 Complete Application Filed

  Priority application(s): 10/281,026 25.10.02 US; 60/510,000 10.10.03 US

17 June 2004 Application Open to Public Inspection

  Published as AU-B-2003275854

11 September 2008 Application Accepted

  Published as AU-B-2003275854

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003275855-Sustained-release tramadol formulations with 24-hour efficacy

2003275853-METHODS AND COMPOSITION FOR REVERSAL OF DIABETES AND USES THEREOF